Pacira BioSciences (PCRX) News Today $26.57 -0.18 (-0.67%) As of 11:15 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock PCRX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Graham Capital Management L.P. Sells 61,645 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX)Graham Capital Management L.P. lowered its holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 83.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 12,268 shares of the company's stock after sellingMay 21 at 4:05 AM | marketbeat.com1,075,673 Shares in Pacira BioSciences, Inc. (NASDAQ:PCRX) Purchased by Point72 Asset Management L.P.Point72 Asset Management L.P. bought a new position in Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 1,075,673 shares of thMay 20 at 5:30 AM | marketbeat.comGotham Asset Management LLC Cuts Position in Pacira BioSciences, Inc. (NASDAQ:PCRX)Gotham Asset Management LLC cut its stake in Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 28.6% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 64,948 shares of the company's stock after selling 25,965 shares during the period.May 20 at 4:29 AM | marketbeat.comPacira BioSciences, Inc. (NASDAQ:PCRX) Shares Sold by Comerica BankComerica Bank reduced its holdings in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 69.7% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 16,134 shares of the company's stock after selling 37,055 shares dMay 19 at 3:30 AM | marketbeat.comNorthern Trust Corp Buys 145,205 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX)Northern Trust Corp increased its stake in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 30.8% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 616,891 shares of the company's stock after acquiring an additional 145,May 19 at 3:17 AM | marketbeat.comNumerai GP LLC Buys Shares of 15,724 Pacira BioSciences, Inc. (NASDAQ:PCRX)Numerai GP LLC bought a new position in Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) in the fourth quarter, according to its most recent disclosure with the SEC. The firm bought 15,724 shares of the company's stock, valued at approximately $296,000. Several other institutional investors havMay 18 at 5:18 AM | marketbeat.comBNP Paribas Financial Markets Sells 173,956 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX)BNP Paribas Financial Markets cut its stake in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 44.0% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 221,739 shares of the company's stock after selling 173,May 17, 2025 | marketbeat.comJacobs Levy Equity Management Inc. Takes $8.56 Million Position in Pacira BioSciences, Inc. (NASDAQ:PCRX)Jacobs Levy Equity Management Inc. purchased a new stake in Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 454,261 shares of the company's stock, valMay 16, 2025 | marketbeat.comPacira BioSciences, Inc. (NASDAQ:PCRX) Shares Sold by Voya Investment Management LLCVoya Investment Management LLC lowered its stake in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 68.2% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 13,948 shares of the company's stock after sellingMay 15, 2025 | marketbeat.comRaymond James Financial Inc. Invests $190,000 in Pacira BioSciences, Inc. (NASDAQ:PCRX)Raymond James Financial Inc. bought a new position in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 10,099 shares of the company's stock, vMay 15, 2025 | marketbeat.comPacira BioSciences to Participate in Fireside Chat at Two Upcoming Healthcare ConferencesMay 14, 2025 | globenewswire.comPacira BioSciences, Inc. (NASDAQ:PCRX) Shares Sold by Algert Global LLCAlgert Global LLC decreased its holdings in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 54.8% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 26,625 shares of the company's stock after selling 32,223 shares during the period. AlgerMay 13, 2025 | marketbeat.comPacira BioSciences, Inc. (NASDAQ:PCRX) Shares Sold by Cubist Systematic Strategies LLCCubist Systematic Strategies LLC lowered its holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 66.3% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 186,952 shares of the company's stock after selling 367,435 shares duMay 12, 2025 | marketbeat.comBokf Na Buys New Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX)Bokf Na purchased a new position in Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 27,212 shares of the company's stock, valued aMay 12, 2025 | marketbeat.comBalyasny Asset Management L.P. Makes New Investment in Pacira BioSciences, Inc. (NASDAQ:PCRX)Balyasny Asset Management L.P. purchased a new stake in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 434,206 shares of the company's stock,May 12, 2025 | marketbeat.comPacira BioSciences (NASDAQ:PCRX) Given New $30.00 Price Target at Needham & Company LLCNeedham & Company LLC reduced their price objective on Pacira BioSciences from $32.00 to $30.00 and set a "buy" rating for the company in a research report on Friday.May 11, 2025 | marketbeat.comTruist Financial Sticks to Its Hold Rating for Pacira Pharmaceuticals (PCRX)May 11, 2025 | theglobeandmail.com33,813 Shares in Pacira BioSciences, Inc. (NASDAQ:PCRX) Bought by Brevan Howard Capital Management LPBrevan Howard Capital Management LP bought a new stake in Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 33,813 shares of tMay 11, 2025 | marketbeat.comAxa S.A. Buys Shares of 89,482 Pacira BioSciences, Inc. (NASDAQ:PCRX)Axa S.A. purchased a new position in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 89,482 shares of the company's stock, valued at approximately $1,686,0May 11, 2025 | marketbeat.comPacira BioSciences, Inc. (NASDAQ:PCRX) Shares Sold by AQR Capital Management LLCAQR Capital Management LLC reduced its holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 47.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 288,499 shares of the company's stock after selling 257,709May 11, 2025 | marketbeat.comTudor Investment Corp ET AL Purchases New Shares in Pacira BioSciences, Inc. (NASDAQ:PCRX)Tudor Investment Corp ET AL acquired a new stake in Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 22,649 shares of the company's stock, valued at approximately $42May 11, 2025 | marketbeat.comPacira BioSciences (NASDAQ:PCRX) Shares Gap Down After Analyst DowngradeMay 11, 2025 | americanbankingnews.comEarnings call transcript: Pacira Q1 2025 shows revenue miss, stock dipsMay 10, 2025 | uk.investing.comPacira outlines growth potential with $725M-$765M 2025 revenue target and EXPAREL expansion to 2039May 10, 2025 | msn.comPacira BioSciences, Inc. (NASDAQ:PCRX) Shares Sold by Caption Management LLCCaption Management LLC lowered its stake in Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 59.3% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 53,844 shares of the company's stock afteMay 9, 2025 | marketbeat.comBridgeway Capital Management LLC Purchases 11,149 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX)Bridgeway Capital Management LLC boosted its stake in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 3.2% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 358,785 shares of the company's stock after buyingMay 9, 2025 | marketbeat.comPacira BioSciences, Inc. (PCRX) Q1 2025 Earnings Call TranscriptMay 8, 2025 | seekingalpha.comPacira BioSciences, Inc. 2025 Q1 - Results - Earnings Call PresentationMay 8, 2025 | seekingalpha.comPacira BioSciences Reports First Quarter 2025 Financial ResultsMay 8, 2025 | globenewswire.comDimensional Fund Advisors LP Decreases Stock Position in Pacira BioSciences, Inc. (NASDAQ:PCRX)Dimensional Fund Advisors LP trimmed its position in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 2.1% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,832,216 shares of the company's stock after sellingMay 7, 2025 | marketbeat.comPacira BioSciences soars 52% following InvestingPro’s October Fair Value alertMay 5, 2025 | investing.comSchonfeld Strategic Advisors LLC Reduces Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX)Schonfeld Strategic Advisors LLC cut its position in Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 46.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 271,654 shares of the company's stock after selling 236,082 sharMay 5, 2025 | marketbeat.comMarshall Wace LLP Sells 482,336 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX)Marshall Wace LLP decreased its stake in Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 91.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 42,613 shares of the company's stock after sellingMay 3, 2025 | marketbeat.comPacira BioSciences to Present New Data on Clinical Immunogenicity of Intra-Articular PCRX-201 and Its Implications for Dosing Strategy in Knee OsteoarthritisMay 2, 2025 | globenewswire.comPacira BioSciences, Inc. (NASDAQ:PCRX) Shares Purchased by PDT Partners LLCPDT Partners LLC boosted its position in Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 7.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 248,607 shares of the company's stock after bMay 1, 2025 | marketbeat.comPacira BioSciences (PCRX) Expected to Announce Quarterly Earnings on TuesdayPacira BioSciences (NASDAQ:PCRX) will be releasing its Q1 2025 earnings before the market opens on Tuesday, May 6. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-6-pacira-biosciences-inc-stock/)May 1, 2025 | marketbeat.comPacira BioSciences, Inc. (NASDAQ:PCRX) Receives Consensus Recommendation of "Hold" from BrokeragesPacira BioSciences, Inc. (NASDAQ:PCRX - Get Free Report) has been given an average rating of "Hold" by the nine brokerages that are presently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, four have issued a hold rating and four have assignedMay 1, 2025 | marketbeat.comPacira BioSciences (NASDAQ:PCRX) Shares Up 3.5% - Still a Buy?Pacira BioSciences (NASDAQ:PCRX) Shares Up 3.5% - Here's WhyApril 30, 2025 | marketbeat.comLPL Financial LLC Purchases Shares of 13,321 Pacira BioSciences, Inc. (NASDAQ:PCRX)LPL Financial LLC purchased a new stake in Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 13,321 shares of the company's stock, valued at approximately $251,000. Other hedge fundApril 30, 2025 | marketbeat.comPacira’s gene therapy shows sustained benefits in trial for knee osteoarthritisApril 29, 2025 | finance.yahoo.comPacira to Report First Quarter 2025 Financial Results on Thursday May 8, 2025April 29, 2025 | globenewswire.comPacira BioSciences Announces Two-Year Efficacy Data Following a Single Local Administration of PCRX-201 in Patients with Mild to Severe Osteoarthritis of the KneeApril 28, 2025 | globenewswire.comInvesco Ltd. Cuts Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX)Invesco Ltd. reduced its holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 74.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 240,446 shares of the company's stock after selling 683,699 shares duringApril 28, 2025 | marketbeat.comZacks Research Has Pessimistic Outlook of PCRX Q1 EarningsPacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) - Equities research analysts at Zacks Research lowered their Q1 2027 earnings estimates for shares of Pacira BioSciences in a research report issued to clients and investors on Tuesday, April 22nd. Zacks Research analyst R. Department now forecApril 27, 2025 | marketbeat.comCanada Pension Plan Investment Board Boosts Stock Position in Pacira BioSciences, Inc. (NASDAQ:PCRX)Canada Pension Plan Investment Board raised its position in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 417.2% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 45,000 shares of the company's stock after buying an additionaApril 27, 2025 | marketbeat.comBarclays PLC Grows Position in Pacira BioSciences, Inc. (NASDAQ:PCRX)Barclays PLC increased its position in Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 4.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 423,221 shares of the company's stock after purchasinApril 26, 2025 | marketbeat.comNatixis Invests $1.74 Million in Pacira BioSciences, Inc. (NASDAQ:PCRX)Natixis acquired a new stake in Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 92,250 shares of the company's stock, valueApril 25, 2025 | marketbeat.comPacira BioSciences (NASDAQ:PCRX) Shares Up 5.7% - Should You Buy?Pacira BioSciences (NASDAQ:PCRX) Trading 5.7% Higher - Time to Buy?April 23, 2025 | marketbeat.comPacira BioSciences to Present 104-Week Efficacy Data Following a Single Local Administration of PCRX-201 for Patients with Mild to Severe Osteoarthritis of the KneeApril 22, 2025 | globenewswire.comXTX Topco Ltd Takes Position in Pacira BioSciences, Inc. (NASDAQ:PCRX)XTX Topco Ltd bought a new position in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor bought 27,738 shares of the company's stock, valued at approximately $523,000. XTX Topco LtApril 22, 2025 | marketbeat.com Get Pacira BioSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for PCRX and its competitors with MarketBeat's FREE daily newsletter. Email Address PCRX Media Mentions By Week PCRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PCRX News Sentiment▼1.570.65▲Average Medical News Sentiment PCRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PCRX Articles This Week▼109▲PCRX Articles Average Week Get Pacira BioSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for PCRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Perrigo News Today Supernus Pharmaceuticals News Today Omeros News Today Nektar Therapeutics News Today Assembly Biosciences News Today Cumberland Pharmaceuticals News Today Eli Lilly and Company News Today Johnson & Johnson News Today AbbVie News Today Merck & Co., Inc. News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PCRX) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pacira BioSciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pacira BioSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PCRX Stock Free PCRX Stock Alerts